The tenth batch! National drug procurement 'unboxing'
2024-12-13
Compared with ordinary doxorubicin products, doxorubicin hydrochloride liposome injection, a first-line drug for breast cancer, can effectively reduce adverse reactions and improve drug safety. And this drug was successfully included in the tenth batch of national organized drug centralized procurement on the 12th, which will greatly reduce the treatment burden on patients. In this centralized procurement, 62 types of drugs were successfully purchased, and 385 products from 234 companies were eligible for selection. Among them, there are commonly used drugs such as aspirin oral release form and penicillin injection, as well as special disease drugs such as doxorubicin hydrochloride liposome injection, which will bring more benefits to patients. "Volume for price", to "afford drugs" for more patients - entecavir, tenofovir, and other antiviral drugs for hepatitis B, the annual cost of patients after centralized procurement decreased from 4000 to 5000 yuan to 100 to 200 yuan; Lenalidomide capsules for the treatment of multiple myeloma were promptly included in the centralized procurement after the patent expired, with each capsule (25mg) reduced from about 200 yuan to 15 yuan, saving patients about 3880 yuan in medication costs per month... As of now, the National Medical Insurance Administration has organized 10 batches of national organized drug procurement in conjunction with relevant departments, covering 435 types of drugs. Behind each round of centralized procurement is the upgrading of people's well-being, bringing more affordable medication to patients. Centralized procurement of non new drugs, and non centralized procurement of new drugs. Centralized procurement reflects the market competitiveness of enterprises and products more by exchanging quantity for price Geng Xiaojun, Deputy Director of the Pharmaceutical Price and Tendering Procurement Department of Beijing Municipal Medical Insurance Bureau, said that the 62 drugs successfully purchased this time are all drugs that have expired their patent period, are produced by multiple enterprises, and have sufficient competition. And 'old drugs' are reduced in price through centralized procurement, freeing up space for more new drugs to be included in medical insurance. According to data from the National Healthcare Security Administration, preliminary estimates suggest that in recent years, the centralized procurement of drugs and consumables has created nearly 500 billion yuan in medical insurance fund space for new drug consumption, new technology access, and medical service price adjustments. Improving quality and expanding coverage, providing more medication choices - In recent years, the coverage of national drug procurement has been continuously expanding. The drugs participating in the centralized procurement this time involve a total of 62 varieties and 263 specifications, setting a new record for the number of national drug centralized procurement in previous years Lu Yun, director of the Medical Price Research Center at China Pharmaceutical University, said that this centralized procurement includes both commonly used drugs and high-end complex drugs, as well as various drugs for cardiovascular, cerebrovascular, digestive and metabolic basic diseases, covering a wide population and improving patients' medication level and quality of life. While expanding its coverage, centralized procurement is also constantly improving its quality. The treatment of rare disease pulmonary arterial hypertension with Macotentin tablets will provide patients with more medication options; The compound preparation of sitagliptin and metformin tablets allows patients to take two mainstream hypoglycemic drugs, sitagliptin and metformin, in one dose, increasing medication convenience... Successful procurement of more drugs will bring practical benefits to patients. On the one hand, this centralized procurement will effectively improve the quality of patients' medication and promote the widespread replacement of unapproved drugs with drugs evaluated for consistency in quality and efficacy; On the other hand, the structure of medication will be improved, and drugs with different mechanisms of action or better therapeutic effects in the same treatment field, which are more convenient to use, will be widely introduced into clinical practice, comprehensively promoting the upgrading of patient medication quality Geng Xiaojun said. Implementing the policy of 'entering the hospital' to facilitate the purchase of drugs through centralized procurement - ensuring drug supply and allowing drugs to truly 'enter thousands of households' after being selected through centralized procurement is a crucial step. This centralized procurement has been adjusted and upgraded in terms of rules to further ensure the supply of drugs and the use of patients Lu Yun introduced that after the selection of the drugs, the newly added specifications and packaging can also be included in the centralized procurement list, providing more choices for clinical use. It is reported that on average, more than 6 companies have won bids for each drug in this centralized procurement, promoting more stable and diversified supply. The medical insurance department will actively promote the supply and stable price of emergency and shortage drugs in the future, and implement a supply mode of "one enterprise as the main supplier and two enterprises as backup suppliers" in each province. At the same time, promote the centralized procurement of drugs into grassroots medical institutions, private medical institutions, and pharmacies, making it convenient for the public to purchase selected drugs nearby. The relevant person in charge of the National Healthcare Security Administration introduced that the next step will be to guide various regions and selected enterprises to carry out the implementation of the selection results, ensuring that patients across the country can use the selected products in this centralized procurement by April 2025. Centralized procurement squeezes out the price "water" and exchanges it for the livelihood "nutrients". We look forward to the gradual implementation of the results of this centralized procurement, so that patients can enjoy more high-quality and affordable drugs. (New Society)
Edit:He Chuanning Responsible editor:Su Suiyue
Source:Xinhua
Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com